Q: As utilization review case managers, we are often tasked with assessing our hospital's risk for novel coronavirus (COVID-19) denials. What are the most important measures we should be examining?
Q: Many organizations have outsourced their PHI disposal for years. With coronavirus limiting the number of people coming in and out of medical facilities, what are your suggestions for organizations that now have to take care of PHI disposal themselves? What are the most important things to remember when handling this process?
Q: Would it be appropriate to use family psychotherapy CPT codes 90846-90849 to report therapy for the benefit one person that involves input from family members?
Q: If researchers want to obtain PHI for a person who died of COVID-19, what is the protocol for releasing that information? What are the HIPAA protections?
Q: As a case manager, part of my job is making sure my patients are capable of utilizing technology to access telemedicine. What are your recommendations for helping patients get up to speed with technology?
Q: We have patients being admitted for novel coronavirus (COVID-19) and most of them have a laundry list of various manifestations and complications. Do all manifestations and complications need to be reported in ICD-10-CM?
Q: As sports leagues attempt to make their return, many are going to be using daily COVID-19 testing as part of their protocol. Obviously, the leagues need to quarantine any individual who tests positive for the virus. But why is the covered entity that is performing the testing allowed to disclose a patient’s test results to the leagues?
Q: How can case managers help patients, especially those dealing with chronic diseases such as diabetes, access care during the novel coronavirus (COVID-19) pandemic?
